Vetsys Pharmaceutical
Vetsys Pharmaceutical
Italy stands as a cornerstone of European agriculture, particularly within the dairy and beef sectors of Lombardy, Piedmont, and Emilia-Romagna. As a premier Sustained-release Boluses Manufacturer & Exporter in Italy, we recognize the shifting paradigms of the Mediterranean livestock market. The Italian veterinary landscape is currently undergoing a digital and pharmacological transformation, driven by the "Precision Livestock Farming" (PLF) initiative. Our advanced sustained-release bolus technology aligns perfectly with the European Union's stringent "Farm to Fork" strategy, which emphasizes the reduction of antimicrobial resistance (AMR) through targeted, long-acting therapy.
In the Po Valley, where dairy production is concentrated, farmers increasingly utilize controlled-release technology to manage trace mineral deficiencies and metabolic disorders. Sustained-release boluses provide a unique advantage by delivering a consistent therapeutic dose over weeks or months, eliminating the need for frequent handling of cattle. This not only improves animal welfare—a high priority for Italian consumers—but also optimizes the labor efficiency of modern Italian farms. Our expertise in polymer-based delivery systems ensures that the active ingredients, such as Oxytetracycline or essential micronutrients, are released at a predictable rate, regardless of the rumen's fluctuating pH levels.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility serves as a global hub for innovation, featuring specialized workshops for producing a comprehensive range of products, including powders, premixes, injections, oral solutions, tablets, and notably, high-tech sustained-release granules and boluses. By 2015, Vetsys achieved annual domestic sales exceeding USD 20 million, cementing our status as one of the top animal pharmaceutical producers in the region.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This high-level infrastructure enables us to quickly adapt to the specific market demands of the Italian and European veterinary sectors, producing cutting-edge solutions like sustained-release boluses that meet the highest bio-availability standards.
With Italy's commitment to the European Green Deal, there is a surging demand for "cleaner" veterinary medicine. Sustained-release boluses reduce the frequency of drug administration, which minimizes environmental leaching and reduces the stress associated with livestock handling. Our products are engineered to be eco-friendly while maintaining therapeutic efficacy.
Italy has been proactive in monitoring veterinary medicinal products via the "ClassyFarm" system. By using sustained-release formulations of Amoxicillin or Tiamulin, veterinarians can ensure precise dosing. This prevent under-dosing—a primary cause of bacterial resistance—making our boluses a preferred choice for responsible Italian cattle and swine breeders.
Livestock in Italy often face heat stress during summer months, which can affect rumen function and metabolic health. Our boluses are tested for stability under various climatic conditions, ensuring that the sustained-release mechanism remains intact even in the warmer southern regions like Sicily and Puglia.
Quality is the cornerstone of our operations. Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions. Our focus on quality management allows us to maintain trust and loyalty among our Italian partners, setting us apart as a reliable manufacturer in the global animal healthcare industry.
Furthermore, Vetsys is committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize our industrial footprint. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation. Our future strategy includes:
Precision Mold Injection
Automated Welding
Robotic Assembly
GMP Packaging
Injection Molding
Blow Molding
Extrusion Molding
Material Processing
Advanced Boluses & Premixes Ready for Italian Export
